Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Pharmaceutical Manufacturing Market Size, Share, Trends, and Forecast, 2026-2033 | Biologics and Automation Drive 5.88% CAGR and USD 990.55 Billion Opportunity

globenewswire.com
PFE Pfizer is listed as a key player in the pharmaceutical manufacturing market, which is projected to grow significantly. The article does not provide specific sentiment towards Pfizer's individual performance. JNJ Johnson & Johnson is mentioned as a participant in the pharmaceutical manufacturing market, which is expected to experience substantial growth. No specific sentiment is attributed to the company. MRK Merck & Co., Inc. is identified as a company within the pharmaceutical manufacturing sector, which is poised for significant expansion. The article does not offer specific sentiment for Merck. LLY Eli Lilly and Company is listed as a participant in the pharmaceutical manufacturing market, which is projected to grow substantially. The article does not provide specific sentiment for the company. ABBV AbbVie, Inc. is mentioned as a company within the pharmaceutical manufacturing market, which is expected to see considerable growth. No specific sentiment is detailed for AbbVie. TMO Thermo Fisher Scientific, Inc. is listed as a key player in the pharmaceutical manufacturing market, which is projected for significant growth. The article does not offer specific sentiment for the company.

Pharmaceutical Manufacturing Market Size, Share, Trends, and Forecast, 2026-2033 | Biologics and Automation Drive 5.88% CAGR and USD 990.55 Billion Opportunity Dublin, Oct. 07, 2026 (GLOBE NEWSWIRE) -- "Pharmaceutical Manufacturing Market Size, Share & Trends Analysis Report by Route of Administration, Molecule Type, Drug Development, Sales Channel, Therapy Area, Prescription, Age Group, Formulation, Region, and Growth Forecasts, 2026-2033" has been added to ResearchAndMarkets.com's offering.

The global pharmaceutical manufacturing market was valued at an estimated USD 616.15 billion in 2025 and is projected to reach USD 990.55 billion by 2033. The market is expected to expand at a compound annual growth rate of 5.88% from 2026 to 2033, supported by rising demand for advanced therapeutics, biologics, biosimilars, and high-volume generic drugs.

Increasing rates of chronic diseases, including cancer, diabetes, cardiovascular conditions, and respiratory disorders, are contributing to sustained demand for pharmaceutical products. Growth in healthcare expenditure, expanding patient populations, and the introduction of advanced treatments are encouraging pharmaceutical manufacturers to increase production capacity while maintaining product quality, safety, and regulatory compliance.

Drug approvals are also supporting pharmaceutical manufacturing market growth. In 2025, the U.S. Food and Drug Administration approved 32 novel drugs, reflecting continued innovation across the pharmaceutical sector and creating additional requirements for scalable, reliable manufacturing processes.

Manufacturers are investing in automation, continuous manufacturing, and high-precision bioprocessing technologies to improve efficiency, optimize production, and strengthen quality control. These technologies can help companies reduce operating costs, accelerate output, and meet stringent regulatory requirements across global markets.

The rapid evolution of drug development technologies is transforming pharmaceutical production strategies. Greater adoption of biologics, biosimilars, monoclonal antibodies, vaccines, cell and gene therapies, and personalized medicines requires flexible manufacturing infrastructure and specialized processing capabilities. Pharmaceutical companies are consequently expanding in-house capacity while also using outsourced manufacturing services to access technical expertise, improve operational flexibility, and respond to changing demand.

Global Pharmaceutical Manufacturing Market Report Segmentation

The report analyzes pharmaceutical manufacturing market revenue at global, regional, and country levels. It examines industry trends and growth opportunities across key segments from 2021 to 2033.

Molecule Type Outlook - Revenue, USD Billion, 2021-2033

Drug Development Outlook - Revenue, USD Billion, 2021-2033

Formulation Outlook - Revenue, USD Billion, 2021-2033

Route of Administration Outlook - Revenue, USD Billion, 2021-2033

Therapy Area Outlook - Revenue, USD Billion, 2021-2033

Prescription Outlook - Revenue, USD Billion, 2021-2033

Age Group Outlook - Revenue, USD Billion, 2021-2033

Sales Channel Outlook - Revenue, USD Billion, 2021-2033

Regional Outlook - Revenue, USD Billion, 2021-2033

Key Benefits of the Pharmaceutical Manufacturing Market Report

The report provides market intelligence for pharmaceutical companies, contract manufacturers, healthcare organizations, investors, technology providers, and other stakeholders seeking to evaluate the future of pharmaceutical manufacturing. Its segment-level and regional forecasts support market assessment, competitive strategy, resource allocation, and the identification of high-growth opportunities through 2033.

Key Attributes:

Key Topics Covered:

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope

1.2. Segment Definitions

1.2.1. Molecule Type

1.2.2. Drug Development Type

1.2.3. Formulation

1.2.4. Routes of Administration

1.2.5. Therapy Area

1.2.6. Prescription

1.2.7. Age Group

1.2.8. Sales Channel

1.3. Estimates and Forecast Timeline

1.4. Research Methodology

1.5. Information Procurement

1.5.1. Purchased Database

1.5.2. Internal Database

1.5.3. Secondary Sources

1.5.4. Primary Research

1.6. Information Analysis

1.6.1. Data Analysis Models

1.7. Market Formulation & Data Visualization

1.8. Model Details

1.8.1. Commodity Flow Analysis

1.9. List of Secondary Sources

1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Snapshot

2.2. Segment Snapshot

2.3. Competitive Landscape Snapshot

Chapter 3. Pharmaceutical Manufacturing Market Variables, Trends, & Scope

3.1. Market Lineage Outlook

3.2. Market Dynamics

3.2.1. Market Driver Analysis

3.2.2. Market Restraint Analysis

3.3. Business Environment Analysis

3.3.1. Industry Analysis - Porter's Five Forces Analysis

3.3.2. PESTLE Analysis

Chapter 4. Pharmaceutical Manufacturing Market: Molecule Type Business Analysis

4.1. Molecule Type Market Share, 2025 & 2033

4.2. Molecule Type Segment Dashboard

4.3. Market Size & Forecasts and Trend Analysis, by Molecule Type, 2021 to 2033 (USD Billion)

4.4. Biologics & Biosimilars (Large Molecules)

4.4.1. Biologics & Biosimilars (Large Molecules) Market Estimates & Forecasts 2021 to 2033 (USD Billion)

4.5. Conventional Drugs (Small Molecules)

4.5.1. Conventional Drugs (Small Molecules) Market Estimates & Forecasts 2021 to 2033 (USD Billion)

Chapter 5. Pharmaceutical Manufacturing Market: Drug Development Business Analysis

5.1. Drug Development Market Share, 2025 & 2033

5.2. Drug Development Segment Dashboard

5.3. Market Size & Forecasts and Trend Analysis, by Drug Development, 2021 to 2033 (USD Billion)

5.4. Outsource

5.4.1. Outsource Market Estimates & Forecasts, 2021-2033 (USD Billion)

5.5. In-house

5.5.1. In-house Market Estimates & Forecasts, 2021-2033 (USD Billion)

Chapter 6. Pharmaceutical Manufacturing Market: Formulation Business Analysis

6.1. Formulation Market Share, 2025 & 2033

6.2. Formulation Segment Dashboard

6.3. Market Size & Forecasts and Trend Analysis, by Formulation, 2021 to 2033 (USD Billion)

6.4. Tablets

6.4.1. Tablets Market Estimates & Forecasts, 2021-2033 (USD Billion)

6.5. Capsules

6.5.1. Capsules Market Estimates & Forecasts, 2021-2033 (USD Billion)

6.6. Injectable

6.6.1. Injectable Market Estimates & Forecasts, 2021-2033 (USD Billion)

6.7. Sprays

6.7.1. Sprays Market Estimates & Forecasts, 2021-2033 (USD Billion)

6.8. Suspensions

6.8.1. Suspensions Market Estimates & Forecasts, 2021-2033 (USD Billion)

6.9. Powders

6.9.1. Powders Market Estimates & Forecasts, 2021-2033 (USD Billion)

6.10. Other

6.10.1. Other Market Estimates & Forecasts, 2021-2033 (USD Billion)

Chapter 7. Pharmaceutical Manufacturing Market: Route of Administration Business Analysis

7.1. Route of Administration Market Share, 2025 & 2033

7.2. Route of Administration Segment Dashboard

7.3. Market Size & Forecasts and Trend Analysis, by Route of Administration, 2021 to 2033 (USD Billion)

7.4. Oral

7.4.1. Oral Market Estimates & Forecasts, 2021-2033 (USD Billion)

7.5. Topical

7.5.1. Topical Market Estimates & Forecasts, 2021-2033 (USD Billion)

7.6. Parenteral

7.6.1. Parenteral Market Estimates & Forecasts, 2021-2033 (USD Billion)

7.7. Inhalations

7.7.1. Inhalations Market Estimates & Forecasts, 2021-2033 (USD Billion)

7.8. Other

7.8.1. Other Market Estimates & Forecasts, 2021-2033 (USD Billion)

Chapter 8. Pharmaceutical Manufacturing Market: Therapy Area Business Analysis

8.1. Therapy Area Market Share, 2025 & 2033

8.2. Therapy Area Segment Dashboard

8.3. Market Size & Forecasts and Trend Analysis, by Therapy Area, 2021 to 2033 (USD Billion)

8.4. Cardiovascular Diseases (CVDs)

8.4.1. Cardiovascular Diseases (CVDs) Market Estimates & Forecasts, 2021-2033 (USD Billion)

8.5. Pain

8.5.1. Pain Market Estimates & Forecasts, 2021-2033 (USD Billion)

8.6. Diabetes

8.6.1. Diabetes Market Estimates & Forecasts, 2021-2033 (USD Billion)

8.7. Cancer

8.7.1. Cancer Market Estimates & Forecasts, 2021-2033 (USD Billion)

8.8. Respiratory Diseases

8.8.1. Respiratory Diseases Market Estimates & Forecasts, 2021-2033 (USD Billion)

8.9. Other

8.9.1. Other Market Estimates & Forecasts, 2021-2033 (USD Billion)

Chapter 9. Pharmaceutical Manufacturing Market: Prescription Business Analysis

9.1. Prescription Market Share, 2025 & 2033

9.2. Prescription Segment Dashboard

9.3. Market Size & Forecasts and Trend Analysis, by Prescription, 2021 to 2033 (USD Billion)

9.4. Prescription Medicine

9.4.1. Prescription Medicine Market Estimates & Forecasts, 2021-2033 (USD Billion)

9.5. Over-the-counter (OTC) Medicines

9.5.1. Over-the-counter (OTC) Medicines Market Estimates & Forecasts, 2021-2033 (USD Billion)

Chapter 10. Pharmaceutical Manufacturing Market: Age Group Business Analysis

10.1. Age Group Market Share, 2025 & 2033

10.2. Age Group Segment Dashboard

10.3. Market Size & Forecasts and Trend Analysis, by Age Group, 2021 to 2033 (USD Billion)

10.4. Children & Adolescents

10.4.1. Children & Adolescents Market Estimates & Forecasts, 2021-2033 (USD Billion)

10.5. Adult

10.5.1. Adult Market Estimates & Forecasts, 2021-2033 (USD Billion)

10.6. Geriatric

10.6.1. Geriatric Market Estimates & Forecasts, 2021-2033 (USD Billion)

Chapter 11. Pharmaceutical Manufacturing Market: Sales Channel Business Analysis

11.1. Sales Channel Market Share, 2025 & 2033

11.2. Sales Channel Segment Dashboard

11.3. Market Size & Forecasts and Trend Analysis, by Sales Channel, 2021 to 2033 (USD Billion)

11.4. Retail

11.4.1. Retail Market Estimates & Forecasts, 2021-2033 (USD Billion)

11.5. Non-Retail

11.5.1. Non-Retail Market Estimates & Forecasts, 2021-2033 (USD Billion)

Chapter 12. Pharmaceutical Manufacturing Market: Regional Estimates & Trend Analysis

12.1. Regional Market Share Analysis, 2025 & 2033

12.2. Regional Market Dashboard

12.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:

12.4. North America

12.4.1. North America Pharmaceutical Manufacturing Market Estimates & Forecasts, 2021-2033 (USD Billion)

12.4.2. U.S.

12.4.3. Canada

12.4.4. Mexico

12.5. Europe

12.5.1. Europe Pharmaceutical Manufacturing Market Estimates & Forecasts, 2021-2033 (USD Billion)

12.5.2. UK

12.5.3. Germany

12.5.4. France

12.5.5. Italy

12.5.6. Spain

12.5.7. Denmark

12.5.8. Sweden

12.5.9. Norway

12.6. Asia-Pacific

12.6.1. Asia-Pacific Pharmaceutical Manufacturing Market Estimates & Forecasts, 2021-2033 (USD Billion)

12.6.2. Japan

12.6.3. China

12.6.4. India

12.6.5. Australia

12.6.6. South Korea

12.6.7. Thailand

12.7. Latin America

12.7.1. Latin America Pharmaceutical Manufacturing Market Estimates & Forecasts, 2021-2033 (USD Billion)

12.7.2. Brazil

12.7.3. Argentina

12.8. Middle East and Africa

12.8.1. Middle East and Africa Pharmaceutical Manufacturing Market Estimates & Forecasts, 2021-2033 (USD Billion)

12.8.2. South Africa

12.8.3. Saudi Arabia

12.8.4. UAE

12.8.5. Kuwait

Chapter 13. Competitive Landscape

13.1. Participant Overview

13.2. Company Market Position Analysis

13.3. Company Categorization

13.4. Strategy Mapping

13.5. Company Profiles/Listing

13.5.1. F. Hoffmann-La Roche Ltd.

13.5.2. Novartis AG

13.5.3. GSK plc

13.5.4. Pfizer, Inc.

13.5.5. Merck & Co., Inc.

13.5.6. AstraZeneca

13.5.7. Johnson & Johnson

13.5.8. Sanofi SA

13.5.9. Eli Lilly and Company

13.5.10. AbbVie, Inc.

13.5.11. Thermo Fisher Scientific, Inc.

13.5.12. Wuxi Apptec

13.5.13. Samsung Biologics

13.5.14. FUJIFILM Biotechnologies

13.5.15. Lonza

13.5.16. Catalent, Inc.

13.5.17. Jubilant Pharmova Limited

List of Tables [235]

List of Figures [123]

Companies Featured

For more information about this report visit https://www.researchandmarkets.com/r/h2cnpm

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.